Immune tolerance: critical issues of factor dose, purity and treatment complications.

Immune tolerance: critical issues of factor dose, purity and treatment complications.

Item
http://www.wikidata.org/entity/Q36661848
International workshop on immune tolerance induction: consensus recommendations.Immune tolerance induction for patients with severe hemophilia A: a critical literature review.The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experience.The literature on inhibitors: articles that influence my management of patients with hemophilia A and high-titer inhibitors.Inhibitors in haemophilia: what have we learned from registries? A systematic review.US Guidelines for immune tolerance induction in patients with haemophilia a and inhibitors.Recent advances in hemophilia B therapy.Induction of immune tolerance to FIX following muscular AAV gene transfer is AAV-dose/FIX-level dependentInduction of tolerance to factor VIII by transient co-administration with rapamycin.Low incidence of factor VIII inhibitors in previously untreated patients during prophylaxis, on-demand treatment and surgical procedures, with Octanate®: interim report from an ongoing prospective clinical study.Immune tolerance induction therapy for patients with hemophilia A and FVIII inhibitors particularly using low-dose regimens.Efficacy and safety of OCTANINE F in children with haemophilia B.Immune tolerance induction in haemophilia A patients with inhibitors by treatment with recombinant factor VIII: a retrospective non-interventional study.
P2860

Immune tolerance: critical issues of factor dose, purity and treatment complications.

Item
http://www.wikidata.org/entity/Q36661848
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Immune tolerance: critical issues of factor dose, purity and treatment complications.
@ast
Immune tolerance: critical issues of factor dose, purity and treatment complications.
@en
type
label
Immune tolerance: critical issues of factor dose, purity and treatment complications.
@ast
Immune tolerance: critical issues of factor dose, purity and treatment complications.
@en
prefLabel
Immune tolerance: critical issues of factor dose, purity and treatment complications.
@ast
Immune tolerance: critical issues of factor dose, purity and treatment complications.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P698
P356
P1433
P1476
Immune tolerance: critical issues of factor dose, purity and treatment complications.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2516.2006.01376.X
P478
P577
P698